MedPath

Efficacy of Mindfulness and TDCS on patients with stroke

Phase 2
Recruiting
Conditions
I63.3, I63
Stroke.
Cerebral infarction
Registration Number
IRCT20090716002195N3
Lead Sponsor
Cognitive Sciences and Technologies Council
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Recruiting
Sex
All
Target Recruitment
72
Inclusion Criteria

No involvement of language area in left hemisphere
Unilateral brain involvement
After 3 months of recent stroke
Possiblity to write and read
Signing of the informed consent
Available and possible to follow-up

Exclusion Criteria

Language area involvement (aphasia)
Past history of stroke
Past history of psyciatric disease

Study & Design

Study Type
interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Change of cognitive scale. Timepoint: Before intervention and after 10 sessions of TDCS therapy and after 8 sessions of Kabat-Zinn mindfulness-based stress reduction treatment program. Method of measurement: Addenbrooke's Cognitive Examinations.;Change of emotional scale. Timepoint: before intervention and after 10 sessions ofTDCS therapy and after 8 sessions of Kabat-Zinn mindfulness-based stress reduction treatment program. Method of measurement: Beck's depression and anxiety inventories.
Secondary Outcome Measures
NameTimeMethod
© Copyright 2025. All Rights Reserved by MedPath